Calls Purchased on Forest Laboratories (FRX)

Shares of Forest Laboratories FRX are lower on the session by 0.03%, currently trading at $31.99. The stock had been moving largely higher over the past two months, but recently sold off and is now trading between the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A short while ago the January 2012 $32.50 call was purchased 2,000 times, on the offer, on open interest of 3,257 contracts. Overall call volume is now running at 2.36x the daily average with 99% of all calls traded being purchases on the offer. Forest Laboratories, Inc. and its subsidiaries develop, manufacture and sell branded forms of ethical drug products. The company's United States products are marketed directly, or detailed, to physicians by its salesforces. It also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners.